Effects of Fish Oil Supplementation in Rheumatoid Arthritis

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 1990 Feb 1

PMID 2138449

Citations 32

Authors

H van der Tempel

J E Tulleken

P C Limburg

F A Muskiet

M H van Rijswijk

Affiliations

Soon will be listed here.

Abstract

Sixteen patients with rheumatoid arthritis entered a trial to determine the clinical and biochemical effects of dietary supplementation with fractionated fish oil fatty acids. A randomised, double blind, placebo controlled crossover design with 12 week treatment periods was used. Treatment with non-steroidal anti-inflammatory drugs and with disease modifying drugs was continued throughout the study. Placebo consisted of fractionated coconut oil. The following results favoured fish oil rather than placebo: joint swelling index and duration of early morning stiffness. Other clinical indices improved but did not reach statistical significance. During fish oil supplementation relative amounts of eicosapentaenoic acid and docosahexaenoic acid in the plasma cholesterol ester and neutrophil membrane phospholipid fractions increased, mainly at the expense of the omega-6 fatty acids. The mean neutrophil leucotriene B4 production in vitro showed a reduction after 12 weeks of fish oil supplementation. Leucotriene B5 production, which could not be detected either in the control or in the placebo period, rose to substantial quantities during fish oil treatment. This study shows that dietary fish oil supplementation is effective in suppressing clinical symptoms of rheumatoid arthritis.

Citing Articles

Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Wang W, Xu Y, Zhou J, Zang Y Clin Rheumatol. 2024; 43(8):2479-2488.

PMID: 38922552 DOI: 10.1007/s10067-024-07040-0.

Fatty acid composition and metabolic partitioning of α-linolenic acid are contingent on life stage in human CD3 T lymphocytes.

West A, von Gerichten J, Irvine N, Miles E, Lillycrop K, Calder P Front Immunol. 2022; 13:1079642.

PMID: 36582247 PMC: 9792684. DOI: 10.3389/fimmu.2022.1079642.

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Gwinnutt J, Wieczorek M, Rodriguez-Carrio J, Balanescu A, Bischoff-Ferrari H, Boonen A RMD Open. 2022; 8(2).

PMID: 35654458 PMC: 9096533. DOI: 10.1136/rmdopen-2021-002167.

The Relationship between Fatty Acids and the Development, Course and Treatment of Rheumatoid Arthritis.

Tanski W, Swiatoniowska-Lonc N, Tabin M, Jankowska-Polanska B Nutrients. 2022; 14(5).

PMID: 35268002 PMC: 8912339. DOI: 10.3390/nu14051030.

The Partitioning of Newly Assimilated Linoleic and α-Linolenic Acids Between Synthesis of Longer-Chain Polyunsaturated Fatty Acids and Hydroxyoctadecaenoic Acids Is a Putative Branch Point in T-Cell Essential Fatty Acid Metabolism.

von Gerichten J, West A, Irvine N, Miles E, Calder P, Lillycrop K Front Immunol. 2021; 12:740749.

PMID: 34675928 PMC: 8523940. DOI: 10.3389/fimmu.2021.740749.

References

Borgeat P, Samuelsson B . Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci U S A. 1979; 76(5):2148-52. PMC: 383554. DOI: 10.1073/pnas.76.5.2148. View

Ford-Hutchinson A, Bray M, Doig M, Shipley M, Smith M . Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980; 286(5770):264-5. DOI: 10.1038/286264a0. View

Palmer R, Stepney R, Higgs G, Eakins K . Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species. Prostaglandins. 1980; 20(2):411-8. DOI: 10.1016/s0090-6980(80)80058-x. View

Klickstein L, Shapleigh C, Goetzl E . Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest. 1980; 66(5):1166-70. PMC: 371556. DOI: 10.1172/JCI109947. View

Parke A, Hughes G . Rheumatoid arthritis and food: a case study. Br Med J (Clin Res Ed). 1981; 282(6281):2027-9. PMC: 1505908. DOI: 10.1136/bmj.282.6281.2027. View

Bray M, Ford-Hutchinson A, Smith M . Leukotriene B4: an inflammatory mediator in vivo. Prostaglandins. 1981; 22(2):213-22. DOI: 10.1016/0090-6980(81)90036-8. View

Uden A, Trang L, Venizelos N, Palmblad J . Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis. Ann Rheum Dis. 1983; 42(1):45-51. PMC: 1001058. DOI: 10.1136/ard.42.1.45. View

Samuelsson B . Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983; 220(4597):568-75. DOI: 10.1126/science.6301011. View

ZIFF M . Diet in the treatment of rheumatoid arthritis. Arthritis Rheum. 1983; 26(4):457-61. DOI: 10.1002/art.1780260402. View

10.

Lee T, Shih C, Corey E, Lewis R, Austen K . Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product. J Biol Chem. 1984; 259(4):2383-9. View

11.

Muskiet F, van Doormaal J, Martini I, Wolthers B, van der Slik W . Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J Chromatogr. 1983; 278(2):231-44. DOI: 10.1016/s0378-4347(00)84782-9. View

12.

Verhagen J, Walstra P, Veldink G, Vliegenthart J, Bruynzeel P . Separation and quantitation of leukotrienes by reversed-phase high-performance liquid chromatography. Prostaglandins Leukot Med. 1984; 13(1):15-20. DOI: 10.1016/0262-1746(84)90097-0. View

13.

Hoover R, Karnovsky M, Austen K, Corey E, Lewis R . Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Proc Natl Acad Sci U S A. 1984; 81(7):2191-3. PMC: 345463. DOI: 10.1073/pnas.81.7.2191. View

14.

Terano T, Salmon J, Moncada S . Biosynthesis and biological activity of leukotriene B5. Prostaglandins. 1984; 27(2):217-32. DOI: 10.1016/0090-6980(84)90075-3. View

15.

Kelley V, Ferretti A, Izui S, Strom T . A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice. J Immunol. 1985; 134(3):1914-9. View

16.

Kremer J, Bigauoette J, Michalek A, Timchalk M, Lininger L, Rynes R . Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet. 1985; 1(8422):184-7. DOI: 10.1016/s0140-6736(85)92024-0. View

17.

Strasser T, Fischer S, Weber P . Leukotriene B5 is formed in human neutrophils after dietary supplementation with icosapentaenoic acid. Proc Natl Acad Sci U S A. 1985; 82(5):1540-3. PMC: 397299. DOI: 10.1073/pnas.82.5.1540. View

18.

Lee T, Hoover R, Williams J, Sperling R, Ravalese 3rd J, Spur B . Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 1985; 312(19):1217-24. DOI: 10.1056/NEJM198505093121903. View

19.

Higgs G . The effects of dietary intake of essential fatty acids on prostaglandin and leukotriene synthesis. Proc Nutr Soc. 1985; 44(2):181-7. DOI: 10.1079/pns19850037. View

20.

Malmsten C . Prostaglandins, thromboxanes, and leukotrienes in inflammation. Semin Arthritis Rheum. 1985; 15(2 Suppl 1):29-35. DOI: 10.1016/s0049-0172(85)80007-x. View